LSAMP and prostate cancer: Frequent gene transecting alterations were observed at the TTC28 (37.1% of 143 samples), LSAMP (31.5%), and PTPRD (23.8%) loci, which have not been extensively studied in prostate cancer, though they have been reported in callsets for certain cohorts (28).